Nils Brünner undertakes interdisciplinary study in the fields of Receptor and Biochemistry through his research. He conducts interdisciplinary study in the fields of Biochemistry and Molecular biology through his research. Many of his studies on Molecular biology apply to Ligation as well. His work often combines Ligation and Polymerase chain reaction studies. He merges Polymerase chain reaction with Amplicon in his study. He performs multidisciplinary studies into Amplicon and Multiplex ligation-dependent probe amplification in his work. His Multiplex ligation-dependent probe amplification study typically links adjacent topics like Exon. Nils Brünner performs multidisciplinary studies into Exon and Gene in his work. Nils Brünner integrates several fields in his works, including Gene and Computational biology.
Nils Brünner performs integrative study on Cancer and Cell growth in his works. In his works, Nils Brünner undertakes multidisciplinary study on Cell growth and Cancer. In most of his Internal medicine studies, his work intersects topics such as Transplantation. Nils Brünner connects Cancer research with Carcinogenesis in his study. Nils Brünner integrates many fields in his works, including Carcinogenesis and Cancer research. Borrowing concepts from Metastatic breast cancer, he weaves in ideas under Breast cancer. Nils Brünner conducts interdisciplinary study in the fields of Metastatic breast cancer and Breast cancer through his research. His Endocrinology study frequently draws connections to other fields, such as Plasminogen activator. In his study, he carries out multidisciplinary Plasminogen activator and Plasminogen activator inhibitor-1 research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Khalid Bajou;Agnès Noël;R. D. Gerard;Véronique Masson.
Nature Medicine (1998)
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
Maxime P. Look;Wim L. J. van Putten;Michael J. Duffy;Nadia Harbeck.
Journal of the National Cancer Institute (2002)
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
Jun Yu;Qiang Feng;Sunny Hei Wong;Dongya Zhang.
The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients
J. A. Foekens;H. A. Peters;M. P. Look;H. Portengen.
Cancer Research (2000)
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.
Jan Grøndahl-Hansen;Ib Jarle Christensen;Christian Rosenquist;Nils Brünner.
Cancer Research (1993)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Catharine M. Sturgeon;Michael J. Duffy;Ulf Håkan Stenman;Hans Lilja.
Clinical Chemistry (2008)
Prognostic Impact of Urokinase, Urokinase Receptor, and Type 1 Plasminogen Activator Inhibitor in Squamous and Large Cell Lung Cancer Tissue
Helle Pedersen;Nils Brünner;Dorthe Francis;Kell Østerlind.
Cancer Research (1994)
The Plasminogen Activator Inhibitor PAI-1 Controls In Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies
Khalid Bajou;Véronique Masson;Robert D. Gerard;Petra M. Schmitt.
Journal of Cell Biology (2001)
Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis
Ross W. Stephens;Hans Jørgen Nielsen;Ib J. Christensen;Ole Thorlacius-Ussing.
Journal of the National Cancer Institute (1999)
The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion
K. Danø;N. Behrendt;N. Brunner;V. Ellis.
Fibrinolysis and Proteolysis (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: